Comparison of model results for
ASPIRIN
Correlation
structure
Odds
ratio 95% CI
Exchangeable
(GEE)
0.26 (0.20, 0.35)
Independent
(SLR)
0.26 (0.19, 0.36)
In this example, predictor values
did not vary within a cluster.
IV. Example 3: Heartburn
Relief Study
Data source: Fictitious crossover
study on heartburn relief.
Subjects: 40 patients; 2 symptom-
provoking meals each; 1 of 2
treatments in random order
TreatmentðRXÞ¼^1 if active RX
0 if standard RX
Response (D): Relief from
symptoms after 2 hours
D¼^1 if yes
0 if no
Each subject has two observations
RX¼ 1
RX¼ 0
RX is time dependent: values
change for each subject (cluster)
A comparison of the odds ratio estimates with
95% confidence intervals for the no-interaction
models of both the GEE model and SLR is
shown on the left. The odds ratio estimates
and 95% confidence intervals are very similar.
This is not surprising, since only a modest
amount of correlation is detected in the work-
ing correlation matrixð^r¼ 0 : 0954 Þ.
In this example, none of the predictor variables
(ASPIRIN, AGE, GENDER, WEIGHT, or
HEIGHT) had values that varied within a clus-
ter. This contrasts with the data used for the
next example in which the exposure variable of
interest is a time-dependent variable.
The final dataset discussed is a fictitious cross-
over study on heartburn relief in which 40 sub-
jects are given two symptom-provoking meals
spaced a week apart. Each subject is adminis-
tered an active treatment for heartburn
(RX¼1) following one of the meals and a stan-
dard treatment (RX¼0) following the other
meal in random order. The dichotomous out-
come is relief from heartburn, determined
from a questionnaire completed 2 hours after
each meal.
There are two observations recorded for each
subject: one for the active treatment and the
other for the standard treatment. The variable
indicating treatment status (RX) is a time-
dependent variable since it can change values
within a cluster (subject). In fact, due to the
design of the study, RX changes values in every
cluster.
Presentation: IV. Example 3: Heartburn Relief Study 555